Peli BioThermal has launched a range of deep frozen temperature controlled packaging options.
The new offerings, with temperature ranges of -80°C to -20°C, can aid in preparations to distribute Covid-19 vaccines and therapeutics to market, the company said.
Peli BioThermal said the new options had come as a result of innovation and adaptation of its long-standing reusable Crēdo Cube, which offers -20°C and -50°C temperatures. Many of the company’s product lines now include a variety of frozen options that cover temperatures of -20°C, -35°C, -50°C and -80°C.
Product lines that offer deep frozen options include Crēdo Cube, CoolGuard Advance, CoolPal Flex, Sherpa Systems, Crēdo Xtreme and Crēdo Cargo shippers, Peli BioThermal said. These lines include parcel and pallet sizes, as well as offering both single use and reusable temperature controlled shippers. Many of these expanded temperature ranges are also available through the Crēdo on demand rental programme.
Peli BioThermal’s vice president of worldwide new product development and engineering Greg Wheatley commented: “We know that pharmaceutical companies are in all phases of the development process for vaccines and therapeutics and working tirelessly to bring safe and effective drug products to market quickly.
“Our engineering team matched this urgency to ensure they have the correct temperature controlled packaging to meet them where they’re at in drug development for the pandemic recovery, from discovery to distribution.”
Peli BioThermal’s deep frozen products use phase change material and dry ice systems to provide frozen payload protection with durations from 72 hours to 144+ hours. Payload capacities range from 1 to 96 litres for parcel shippers and 371 to 1,686 litres for pallet shippers.